Mathieu Flamini, who retired from professional football in 2019, has since forged a highly successful career as a businessman in the biochemistry sector. Recent reports suggest the former French international is open to acquiring a stake in Arsenal, a club with which he shares a profound and personal connection.
Flamini’s journey from a professional footballer to a thriving entrepreneur is truly remarkable. While initial reports of his billionaire status in 2018 were inaccurate, by 2026, his financial success is substantial. Valued at an estimated £10 billion, his fortune primarily stems from his biochemical company, ‘GF Biochemicals’. The former Gunners midfielder is now reportedly keen to invest in the London club that played such a significant role in his career.
Sources indicate that Mathieu Flamini is considering purchasing shares in Arsenal, currently owned by American businessman Stan Kroenke. “It goes without saying that these clubs (Arsenal and Marseille) hold a special place in my heart. I never forget where I come from,” stated the 42-year-old former player, emphasizing his strong emotional ties to his past teams.
A Deep-Rooted Connection to Arsenal
After developing his skills at Olympique de Marseille, Mathieu Flamini made a significant move to Arsenal. He went on to make 153 appearances for the Gunners between 2004 and 2008, and an additional 93 matches between 2013 and 2016, following a successful stint with AC Milan. These two periods at Arsenal are widely considered the peak of his career, during which he achieved a notable number of trophies. He also famously participated in the 2006 Champions League final with Arsenal at the Stade de France against FC Barcelona.
Evidently, the London club was instrumental in shaping the career of the former Marseille player. It was also during his tenure at Arsenal that Mathieu Flamini earned his three caps for the French national team in 2007 and 2008. This rich history provides a compelling motivation for him to now consider supporting his former team in a new and impactful capacity.
